Literature DB >> 8458530

Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role?

L Patti1, G Romano, L Di Marino, G Annuzzi, M Mancini, G Riccardi, A A Rivellese.   

Abstract

Very low density lipoproteins (VLDL) have an abnormal lipid composition in Type 1 (insulin-dependent) diabetic patients. Since VLDL represent a heterogeneous lipoprotein class, this might be due either to a shift in the distribution or to an abnormal composition of VLDL subclasses or both. In order to investigate these possibilities and to evaluate possible pathogenetic mechanisms, lipid composition (non-esterified and esterified cholesterol, triglycerides, phospholipids) of four VLDL subfractions of decreasing size (A: Svedberg flotation unit [Sf] > 400, B: Sf > 400, B: Sf 175-400, C: Sf 100-175, D: Sf 20-100), isolated by density gradient preparative ultracentrifugation, and plasma post-heparin lipolytic activity (lipoprotein lipase and hepatic lipase) were evaluated in 13 male normolipidaemic insulin-dependent diabetic patients in good glycaemic control (HbAlc 6.9 +/- 0.5%) (mean +/- SEM) and 9 male control subjects matched for age, body mass index and plasma lipid values. Compared to control subjects, diabetic patients showed a reduced total lipid concentration of VLDL of intermediate size (B and C) reaching statistical significance only for VLDL C (0.16 +/- 0.02 vs 0.24 +/- 0.03 mmol/l; p < 0.05). Expressing each VLDL subfraction as percent of the total VLDL lipid concentration, a significant decrease in particles of intermediate size (C) (20.5 +/- 1.6 vs 27.9 +/- 1.5%; p < 0.005) was present, which was compensated by an increase in the smallest ones (D) (50.5 +/- 2.7 vs 37.4 +/- 3.1%; p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458530     DOI: 10.1007/bf00400698

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation.

Authors:  G M Kostner
Journal:  Clin Chem       Date:  1976-05       Impact factor: 8.327

3.  Lipoprotein fractionation.

Authors:  K Carlson
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

4.  [A practical enzymatic cholesterol determination].

Authors:  F Stähler; W Gruber; K Stinshoff; P Röschlau
Journal:  Med Lab (Stuttg)       Date:  1977-02

5.  The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus.

Authors:  A O Pietri; F L Dunn; S M Grundy; P Raskin
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

6.  Surface modification of Beckman Ultra-Clear centrifuge tubes for density gradient centrifugation of lipoproteins.

Authors:  L Holmquist
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

7.  Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.

Authors:  R W James; D Pometta
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

8.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

9.  A high-performance liquid chromatography method for hemoglobin A1c.

Authors:  J E Davis; J M McDonald; L Jarett
Journal:  Diabetes       Date:  1978-02       Impact factor: 9.461

10.  Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man.

Authors:  A Nicoll; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-12       Impact factor: 4.686

View more
  4 in total

1.  Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.

Authors:  T Ebara; K Conde; Y Kako; Y Liu; Y Xu; R Ramakrishnan; I J Goldberg; N S Shachter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 2.  Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study.

Authors:  A L Puttagunta; E L Toth
Journal:  CMAJ       Date:  1998-02-24       Impact factor: 8.262

3.  Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?

Authors:  L Patti; L Di Marino; A Maffettone; G Romano; G Annuzzi; G Riccardi; A A Rivellese
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice.

Authors:  Yue Zhang; Wenhua He; Cong He; Jianhua Wan; Xiao Lin; Xi Zheng; Lei Li; Xueyang Li; Xiaoyu Yang; Bingjun Yu; Xunde Xian; Yin Zhu; Yuhui Wang; George Liu; Nonghua Lu
Journal:  Cell Death Dis       Date:  2019-09-30       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.